Lulu Wang

5PUBLICATIONS
45CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMolecular targetsEcological impacts of climate change and ecological adaptation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 24, 2026
LM103, an autologous tumor-infiltrating lymphocyte monotherapy, in patients with advanced melanoma resistant to standard therapy.

|Sep 02, 2026
GTPase RAB31 supports ANXA1-driven macrophage education through clathrin-mediated endocytosis to suppress antitumor immunity.

|Jul 11, 2025
BRD4770 protects against DOX-induced cardiotoxicity by inhibiting apoptosis and ferroptosis.

Jingrong Shao, Rui Xiao, Ting Wang

|May 22, 2025
PIKfyve Inhibition Induces Antitumor Immunogenicity by Attenuating STING Trafficking and Lysosomal Degradation.

Jie He, Rui Huang, Chunyan Zong

|Mar 31, 2021
Loss of ARID1A activates mTOR signaling and SOX9 in gastric adenocarcinoma-rationale for targeting ARID1A deficiency.

Xiaochuan Dong, Shumei Song, Yuan Li

Pageof 1

Frequent Collaborators

1 joint publications

Shumei Song

1 joint publications

Zhenning Wang

1 joint publications

Guang Peng

1 joint publications

Jaffer A Ajani